PROTAC AR-V7 degrader-1 is a selective degrader targeting the AR-V7 variant, utilizing the VHL E3 ligase to link to the androgen receptor’s DNA binding domain. This orally bioavailable compound demonstrates effective degradation of AR-V7 in relevant cell lines, showcasing its potential in targeting this specific protein interaction.
Usually ships within 24 hours.